GPER1 and ovarian carcinoma: Some studies have shown higher GPER expression in benign tissue and low-malignancy tumours than in ovarian cancer and reported that GPER was predominantly detected during the early stages of the disease and in tumours with low grading, with high GPER expression associated with favourable clinical outcomes [82,83,84].